US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 267 actively recruiting studies with Colorado sites out of 267 registered in total. The busiest research areas in Colorado are Solid Tumor, Ovarian Cancer, Acute Myeloid Leukemia. Leading sponsors running trials in the state include University of Colorado, Denver, Janssen Research & Development, LLC, National Cancer Institute (NCI). By stage, Colorado trials break down as Phase 1 (52), Phase 2 (80), Phase 3 (81), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
267
Recruiting Now
267
← Back to US Map
Top Conditions in Colorado
Solid Tumor (6)Ovarian Cancer (5)Acute Myeloid Leukemia (4)Cervical Cancer (4)Breast Cancer (4)Prostate Cancer (4)Heart Failure (4)Pancreatic Ductal Adenocarcinoma (PDAC) (3)Neoplasm Metastasis (3)Endometrial Cancer (3)Melanoma (3)Migraine (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 267 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 267. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Ovarian Cancer, Acute Myeloid Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT02455193 N/A
Recruiting
Neuronal Effects of Exercise in Schizophrenia
Condition
Schizophrenia
Enrollment
140 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05000515 N/A
Recruiting
Inspiratory Muscle Strength Training for Lowering Blood Pressure and Improving E...
Condition
Aging
Enrollment
90 pts
Location
United States
Sponsor
University of Colorado, Boulde
View Trial →
NCT06030063 N/A
Recruiting
The Society for Obstetric Anesthesia and Perinatology Research Network General A...
Condition
Cesarean Delivery
Enrollment
5,000 pts
Location
United States, Canada
Sponsor
Yale University
View Trial →
NCT05561387 Phase 3
Recruiting
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM)...
Condition
Plasma Cell Myeloma
Enrollment
510 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT03388606 N/A
Recruiting
Characterization and Treatment of Adolescent Depression
Condition
Depression
Enrollment
4,100 pts
Location
United States
Sponsor
National Institute of Mental H
View Trial →
NCT06532006 Phase 3
Recruiting
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemothera...
Condition
Gastroesophageal-junction Cancer
Enrollment
550 pts
Location
United States, Argentina, Australia
Sponsor
Shanghai Henlius Biotech
View Trial →
NCT07518186 Phase 3
Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or ...
Condition
Multiple Myeloma
Enrollment
700 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
View Trial →
NCT03406611 Phase 1, Phase 2
Recruiting
Pegtibatinase as a Treatment for Patients With Classical Homocystinuria (HCU) (A...
Condition
Homocystinuria
Enrollment
39 pts
Location
United States, France, Qatar
Sponsor
Travere Therapeutics, Inc.
View Trial →
NCT06952699 Phase 2
Recruiting
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Condition
Narcolepsy Type 2
Enrollment
88 pts
Location
United States, China, France
Sponsor
Takeda
View Trial →
NCT06603844 Phase 1, Phase 2
Recruiting
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Condition
Solid Tumor
Enrollment
156 pts
Location
United States, United Kingdom
Sponsor
Corbus Pharmaceuticals Inc.
View Trial →
NCT06479135 Phase 3
Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With ...
Condition
Myelofibrosis
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Kartos Therapeutics, Inc.
View Trial →
NCT06997497 Phase 3
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy ...
Condition
Colon Adenocarcinoma
Enrollment
477 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06462235 Phase 2
Recruiting
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infan...
Condition
Gram-negative Bacterial Infection
Enrollment
48 pts
Location
United States, Argentina, Bulgaria
Sponsor
Pfizer
View Trial →
NCT07761117 Phase 3
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Ad...
Condition
Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment
6,950 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05172960 N/A
Recruiting
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
Condition
Aortic Stenosis, Severe
Enrollment
1,234 pts
Location
United States, Australia, Canada
Sponsor
Edwards Lifesciences
View Trial →
NCT03959085 Phase 3
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With ...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
5,951 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT06398418 Phase 1
Recruiting
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on ...
Condition
Solid Tumor, Adult
Enrollment
33 pts
Location
United States
Sponsor
Rise Therapeutics LLC
View Trial →
NCT06033950 Phase 3
Recruiting
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With ...
Condition
Heart Failure
Enrollment
2,600 pts
Location
United States, Argentina, Brazil
Sponsor
Colorado Prevention Center
View Trial →
NCT07618117 N/A
Recruiting
Improving Sleep Health and Circadian Timing to Support Cardiometabolic Health in...
Condition
Overweight Adolescents
Enrollment
60 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05265273 Phase 2, Phase 3
Recruiting
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized...
Condition
Myasthenia Gravis
Enrollment
12 pts
Location
United States, Japan, Netherlands
Sponsor
Janssen Research & Development
View Trial →
NCT06952803 Phase 3
Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standar...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT07819773 N/A
Recruiting
Device for Treating Generalized Anxiety
Condition
Generalized Anxiety Disorder (GAD)
Enrollment
40 pts
Location
United States
Sponsor
BTL Industries Ltd.
View Trial →
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
View Trial →
NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06535854 N/A
Recruiting
Prevail Global Study
Condition
Coronary Artery Disease
Enrollment
1,205 pts
Location
United States, Canada, Germany
Sponsor
Medtronic Vascular
View Trial →
Page 10 of 11 — 267 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology